• Life Sciences Court Report
    in: Court Report  | 

    Life Sciences Court Report

    By Bryan Helwig — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Celgene Corp. v. Synthon Pharmaceuticals, Inc. 2:18-cv-10775; filed June 19, 2018 in the District of New Jersey (Newark) • Plaintiffs: Celgene Corp. • Defendants: Alvogen Pine Brook, LLC; Synthon BV; Synthon Pharmaceuticals, Inc.; and Synthon S.R.O Claim: Infringement of U.S. Patent Nos.: • 8,198,262: ″Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione″ • 8,673,939: ″Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione″ • 8,735,428: ″Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione″…

  • Conference & CLE Calendar
    in: Conferences & CLE's  | 

    Conference & CLE Calendar

    July 17, 2018 – “Drafting and Defending Software Patents to Survive Section 101 and AIA Challenges — Anticipating and Minimizing the Risk of 101, 103 Rejections, Recent Court Guidance” (Strafford) – 1:00 to 2:30 pm (EDT) July 17, 2018 – Technology Cen…

  • 後述
    in:  | 

    後述

                            目次はこちら

    後述

    (BELOW)
    $$ The ion mobility spectrometer or separator 3 may take a number of different forms which will be discussed in more detail below. / イオ…